Tufts, Harvard Pilgrim top NCQA’s list of best insurance plans

Laura Pedulli | | Health Exec | Quality

The National Community for Quality Assurance, a private non-profit organization focused on improving healthcare quality, has ranked Tufts Health Plan and Harvard Pilgrim as the top insurers based on their quality measures from three performance subcategories—consumer experience, prevention and treatment—and NCQA accreditation.

The NCQA rankings, which include 507 private commercial plans and 136 Medicaid plans, specifically reflect insurers’ combined Healthcare Effectiveness Data and Information Set, Consumer Assessment of Healthcare Providers and Systems and NCQA Accreditation standards scores.

“Being recognized for offering the nation’s top-ranked private and Medicaid health plans is tremendous recognition that reflects our unwavering commitment to providing affordable, high-quality health care coverage to our members no matter their age or life circumstance,” said James Roosevelt Jr., CEO of Tufts Health Plan, in a statement.

The rankings are used on ConsumerReports.org, a nonprofit organization that offers consumer education on products and services. To view the entire list, go here.

 

Laura Pedulli

Related Content

FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight
The top 25 children's heart hospitals in the US
Study ranks US health system dead last among wealthy nations
The 25 top US hospitals for diabetes care
The 25 best heart hospitals in the United States

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.